Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.24.1.u1
Stockholders' Equity (Tables)
9 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Summary of Stock Option Activity

The following table summarizes stock option activity:

 

 

Options

 

 

Weighted-Average Exercise Price Per Share

 

 

Aggregate
Intrinsic Value
(in thousands)

 

 

Weighted-Average Grant Date Fair Value Per Award

 

Fiscal 2023

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at June 30, 2022

 

 

1,779,460

 

 

$

7.84

 

(1)

$

43,433

 

 

$

3.51

 

Granted

 

 

10,000

 

 

$

39.69

 

 

$

 

(2)

$

16.56

 

Exercises

 

 

(275,040

)

 

$

6.67

 

 

$

6,511

 

 

$

3.63

 

Outstanding at March 31, 2023

 

 

1,514,420

 

 

$

7.09

 

 

$

41,786

 

 

$

3.57

 

Exercisable at March 31, 2023

 

 

981,931

 

 

$

5.70

 

 

$

28,429

 

 

$

2.75

 

Fiscal 2024

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at June 30, 2023

 

 

1,446,260

 

 

$

7.11

 

 

$

43,882

 

 

$

3.58

 

Exercises

 

 

(223,396

)

 

$

6.26

 

 

$

5,909

 

 

$

3.66

 

Outstanding at March 31, 2024

 

 

1,222,864

 

 

$

7.26

 

 

$

28,736

 

 

$

3.57

 

Exercisable at March 31, 2024

 

 

1,056,196

 

 

$

5.38

 

 

$

26,728

 

 

$

2.74

 

 

(1) On September 9, 2022 a required adjustment to the outstanding options was triggered as a result of the non-recurring special divided that lowered the exercise strike price by $1.00.

(2) The Company issued the options with an exercise price per share not less than the closing market price of common stock on the grant date.

Summary of Information about Stock Option Outstanding and Exercisable

The following table summarizes information about stock options as of March 31, 2024:

Exercise Price Ranges

 

 

Options Outstanding

 

 

Options Exercisable

 

From

 

 

To

 

 

Number of
 Underlying
 Shares

 

 

Weighted-Average Remaining Contractual Life
(Years)

 

 

Weighted-Average Exercise Price

 

 

Number of
 Underlying
 Shares

 

 

Weighted-Average Remaining Contractual Life
(Years)

 

 

Weighted-Average Exercise Price

 

$

 

 

$

5.00

 

 

 

584,862

 

 

 

5.41

 

 

$

1.99

 

 

 

584,862

 

 

 

5.41

 

 

$

1.99

 

$

5.01

 

 

$

7.50

 

 

 

16,000

 

 

 

2.55

 

 

$

6.31

 

 

 

16,000

 

 

 

2.55

 

 

$

6.31

 

$

7.51

 

 

$

12.50

 

 

 

400,000

 

 

 

1.89

 

 

$

8.83

 

 

 

400,000

 

 

 

1.89

 

 

$

8.83

 

$

12.51

 

 

$

30.00

 

 

 

212,002

 

 

 

6.66

 

 

$

17.40

 

 

 

55,334

 

 

 

5.77

 

 

$

16.08

 

$

30.01

 

 

$

50.00

 

 

 

10,000

 

 

 

8.85

 

 

$

39.69

 

 

 

 

 

 

 

 

$

 

 

 

 

 

 

 

1,222,864

 

 

 

4.46

 

 

$

7.26

 

 

 

1,056,196

 

 

 

4.05

 

 

$

5.38

 

 

Summary of Nonvested Stock Option Activity

The following table summarizes nonvested stock option activity:

 

 

Options

 

 

 

Weighted-Average Grant Date Fair Value Per Award

 

Nonvested outstanding at June 30, 2023

 

 

270,669

 

 

 

$

8.14

 

Vested

 

 

(104,001

)

 

 

$

7.09

 

Nonvested outstanding at March 31, 2024

 

 

166,668

 

 

 

$

8.80

 

Summary of Restricted Stock Unit Activity

The following table summarizes RSU activity:

 

 

Awards
Outstanding

 

 

 

Weighted-Average Fair Value per Unit at Grant Date

 

 

Fiscal 2023

 

 

 

 

 

 

 

 

Nonvested outstanding at June 30, 2022

 

 

56,093

 

 

 

$

32.58

 

 

Granted

 

 

16,435

 

 

 

$

29.21

 

 

Vested & delivered

 

 

(3,296

)

 

 

$

36.38

 

 

Vested & deferred (1)

 

 

(10,147

)

 

 

$

35.46

 

 

Nonvested outstanding at March 31, 2023

 

 

59,085

 

 

 

$

30.93

 

 

Vested but subject to deferred settlement at March 31, 2023 (1)

 

 

29,341

 

 

 

$

24.53

 

 

Outstanding at March 31, 2023

 

 

88,426

 

 

 

$

28.81

 

 

Fiscal 2024

 

 

 

 

 

 

 

 

Nonvested outstanding at June 30, 2023 (2)

 

 

63,587

 

 

 

$

32.37

 

 

Granted

 

 

26,651

 

 

 

$

25.28

 

 

Vested & delivered

 

 

(10,481

)

 

 

$

30.53

 

 

Vested & deferred (1)

 

 

(12,540

)

 

 

$

28.71

 

 

Nonvested outstanding at March 31, 2024 (2)

 

 

67,217

 

 

 

$

30.53

 

 

Vested but subject to deferred settlement at March 31, 2024 (1)

 

 

41,910

 

 

 

$

25.76

 

 

Outstanding at March 31, 2024 (2)

 

 

109,127

 

 

 

$

28.70

 

 

 

(1) Certain RSU holders elected to defer settlement of the RSUs to a specified date. The DSU holder is contractually obligated to defer settlement of the DSUs to a specified date following the holder’s termination of service.

(2) Includes 9,397 RSUs that vest based on continuous employment and achievement of non-market performance goals through June 30, 2024, 2025, and 2026.